Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D

Metabolism. 2004 Feb;53(2):138-9. doi: 10.1016/j.metabol.2003.09.004.

Abstract

The dyslipidemia of the metabolic syndrome is associated with alterations in triglyceride and high-density lipoprotein (HDL) metabolism. We examined the serum levels of glycosylphosphatidylinositol-specific phospholipase D (GPI-PLD), a minor HDL-associated protein, in a cohort with a wide range of insulin sensitivity. The mean serum GPI-PLD mass from 109 subjects was 58.9 +/- 18.4 microg/mL (mean +/- SD). GPI-PLD levels directly correlated with cholesterol, apolipoprotein AI, triglycerides, insulin, and homeostasis model assessment (HOMA) but not C-reactive protein. These results suggest that increased serum GPI-PLD is associated with the insulin resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Apolipoprotein A-I / blood
  • Blood Glucose / metabolism
  • C-Reactive Protein / metabolism
  • Cholesterol / blood
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Insulin / blood
  • Insulin Resistance / physiology*
  • Male
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / enzymology
  • Middle Aged
  • Phospholipase D / blood*
  • Triglycerides / blood

Substances

  • Apolipoprotein A-I
  • Blood Glucose
  • Insulin
  • Triglycerides
  • C-Reactive Protein
  • Cholesterol
  • Phospholipase D
  • glycoprotein phospholipase D